www.cambridge-medical.com/esa/contents/EPP.htm -
[Cached Version]
Published on: 4/15/2006
Last Visited: 5/21/2008
Click to hear Professor Frederic Camu (Department of Anaesthesiology, Flemish Free University of Brussels Medical Centre, Belgium) discussing the analgesic efficacy and opioid-sparing properties of parecoxib - a novel, injectable COX-2 specific inhibit
...
Professor Camu highlighted that parecoxib has a considerable opioid-sparing effect, reducing postoperative morphine consumption by approximately one-third.
Professor Frederic Camu
Figure 1.Parecoxib, the injectable COX-2 specific inhibitor prodrug of valdecoxib
...
Potentially there are great clinical benefits from reduced postoperative opioid use, says Professor Camu.
...
Click to hear Professor Frederic Camu (Department of Anaesthesiology, Flemish Free University of Brussels Medical Centre, Belgium) discussing the analgesic efficacy and opioid-sparing properties of parecoxib - a novel, injectable COX-2 specific inhibit